Cargando…
Cost-Effectiveness Analysis of the Prophylactic Use of Ertapenem for the Prevention of Surgical Site Infections after Elective Colorectal Surgery
Standard surgical antimicrobial prophylaxis (SAP) regimens are less effective in preventing surgical site infections (SSIs) due to rising antimicrobial resistance (AMR) rates, particularly for patients undergoing colorectal surgery. This study aimed to evaluate whether ertapenem should be a preferre...
Autores principales: | Vicentini, Costanza, Gianino, Maria Michela, Corradi, Alessio, Marengo, Noemi, Bordino, Valerio, Corcione, Silvia, De Rosa, Francesco Giuseppe, Fattore, Giovanni, Zotti, Carla Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999678/ https://www.ncbi.nlm.nih.gov/pubmed/33806477 http://dx.doi.org/10.3390/antibiotics10030259 |
Ejemplares similares
-
A cross‐sectional study of SARS‐CoV‐2 seropositivity among healthcare workers and residents of long‐term facilities in Italy, January 2021
por: Bordino, Valerio, et al.
Publicado: (2022) -
Serological Responses up to 9 Months following COVID-19 mRNA Vaccination in Residents and Health-Care Workers of Long-Term Care Facilities: A Multicenter Prospective Cohort Study in Northern Italy
por: Vicentini, Costanza, et al.
Publicado: (2022) -
Antibody responses to BNT162b2 SARS‐CoV‐2 mRNA vaccine among healthcare workers and residents of long‐term care facilities: A cohort study in Northern Italy
por: Vicentini, Costanza, et al.
Publicado: (2023) -
Hand Hygiene Practices during the COVID-19 Pandemic in Northern Italy: Assessment of Compliance Rates Measured by Direct Observation and Alcohol-Based Handrub Usage
por: Vicentini, Costanza, et al.
Publicado: (2022) -
Seroprevalence of infection-induced SARS-CoV-2 antibodies among health care users of Northern Italy: results from two serosurveys (October-November 2019 and September-October 2021)
por: Vicentini, Costanza, et al.
Publicado: (2022)